您的位置：首页 > 产品中心 > JIM3
产品别名
JIM3
JIM-3
JIM 3
JIM
产品性质
| biological source【生物来源】 | human blood |
| growth mode【生长模式】 | Suspension |
| karyotype【核型】 | Not specified |
| morphology【形态学】 | Small spherical |
| products【产品】 | Not specified |
| receptors【受体】 | Not specified |
| technique(s) | cell culture | mammalian: suitable |
| relevant disease(s)【相关疾病】 | cancer |
| shipped in【运输】 | dry ice |
基本信息
| Cell Line Origin【细胞系来源】 | Human myeloma, cancer |
| Cell Line Description【细胞系描述】 | JIM3 is a myeloma tumour line demonstrating typical plasma cell phenotype (CD38, PCA-1 8A and CD24 positive), deficient in DNA repair. JIM3 was derived from plasma myeloma cells derived from pleural fluid of advanced multiple myeloma patient, homoplastic with JIM1. Used for in vitro study and comparison of genetic instability in myeloma tumour lines (homoplastic with JIM1) and the in vitro study of effects of DNA repair deficiency in myeloma tumour lines |
| DNA Profile【DNA图谱分析】 | Not specified |
| Culture Medium【培养基】 | Dexter culture medium, consisting of Fischer′s medium + 20% FCS +10-7 M hydrocortisone sodium succinate |
| Subculture Routine【传代培养常规】 | Seed at 2-9 x 105 cells/cm3 5% CO2; 37 ℃. |
| Other Notes【其他说明】 | Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information. |
产品说明
| Disclaimer【免责声明】 | This cell line has special release conditions: Commercial organisations are required to complete the ′Cell Line Release Authorisation for Research Use in Commercial Organisations′ release conditions form. |
